Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| 1 |
CRH
CRH
|
$872M |
| 2 |
Welltower
WELL
|
$785M |
| 3 |
Kenvue
KVUE
|
$631M |
| 4 |
Simon Property Group
SPG
|
$575M |
| 5 |
Extra Space Storage
EXR
|
$343M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$744M |
| 2 |
Johnson & Johnson
JNJ
|
$664M |
| 3 |
Apple
AAPL
|
$565M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
$408M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$370M |
Sector Composition
| 1 | Technology | 27.06% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 12.92% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Communication Services | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Stitch Fix
SFIX
$737M
| $176K | ﹤0.01% |
+51,001
| New | +$176K |
|
|
EXAI
1952
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $172K | ﹤0.01% |
38,079
| – | – |
|
|
NOAH
1953
Noah Holdings
NOAH
$797M
| $163K | ﹤0.01% |
13,035
-67,769
| -84% | -$845K |
|
1954
Nektar Therapeutics
NKTR
$764M
| $156K | ﹤0.01% |
17,431
| – | – |
|
|
NVTA
1955
DELISTED
Invitae Corporation
NVTA
| $145K | ﹤0.01% |
239,176
| – | – |
|
1956
AudioCodes
AUDC
$274M
| $123K | ﹤0.01% |
12,107
| – | – |
|
|
BLUE
1957
DELISTED
bluebird bio
BLUE
| $114K | ﹤0.01% |
1,870
| – | – |
|
1958
Atea Pharmaceuticals
AVIR
$267M
| $109K | ﹤0.01% |
36,200
-700
| -2% | -$2.1K |
|
1959
EverQuote
EVER
$860M
| $95.4K | ﹤0.01% |
13,200
-117,700
| -90% | -$851K |
|
1960
Fate Therapeutics
FATE
$116M
| $90.5K | ﹤0.01% |
42,672
-245,000
| -85% | -$519K |
|
1961
Nexa Resources
NEXA
$641M
| $75.5K | ﹤0.01% |
12,486
| – | – |
|
1962
Lumen
LUMN
$4.87B
| $64.1K | ﹤0.01% |
45,161
-6,952,486
| -99% | -$9.87M |
|
1963
Axogen
AXGN
$735M
| $58.2K | ﹤0.01% |
11,635
| – | – |
|
|
HUYA
1964
Huya Inc
HUYA
$796M
| $43.5K | ﹤0.01% |
15,300
-180,505
| -92% | -$513K |
|
1965
Liberty Latin America Class A
LILA
$1.6B
| $13.7K | ﹤0.01% |
1,680
-165,900
| -99% | -$1.35M |
|
1966
Brown-Forman Class A
BF.A
$13.8B
| $7.9K | ﹤0.01% |
136
| – | – |
|
1967
Akero Therapeutics
AKRO
$3.58B
| – | – |
-136,377
| Closed | -$6.37M |
|
1968
Alector
ALEC
$305M
| – | – |
-533,791
| Closed | -$3.21M |
|
1969
Amylyx Pharmaceuticals
AMLX
$910M
| – | – |
-84,100
| Closed | -$1.81M |
|
1970
AMERISAFE
AMSF
$871M
| – | – |
-5,500
| Closed | -$293K |
|
1971
Arhaus
ARHS
$1.62B
| – | – |
-244,300
| Closed | -$2.55M |
|
1972
Arlo Technologies
ARLO
$1.89B
| – | – |
-418,800
| Closed | -$4.57M |
|
1973
ASML
ASML
$307B
| – | – |
-2,659
| Closed | -$1.93M |
|
1974
Astria Therapeutics
ATXS
$424M
| – | – |
-32,300
| Closed | -$269K |
|
1975
Build-A-Bear
BBW
$854M
| – | – |
-97,200
| Closed | -$2.08M |
|